Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets
Abstract
:1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Preparation of Microfibrous Sheets by Electrospinning
2.3. Morphology Investigation by Scanning Electron Microscopy (SEM)
2.4. ATR-FTIR Spectroscopic Examinations
2.5. Determination of Drug Content of FEN-Loaded Microfibers
2.6. Dissolution Studies
2.7. Positron Lifetime Measurements
3. Results and Discussion
4. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Hann, M.M. Molecular obesity, potency and other addictions in drug discovery. MedChemComm 2011, 2, 349–355. [Google Scholar] [CrossRef]
- Hill, A.P.; Young, R.J. Getting physical in drug discovery: A contemporary perspective on solubility and hydrophobicity. Drug Discov. Today 2010, 15, 648–655. [Google Scholar] [CrossRef] [PubMed]
- Li, D.; Kerns, E.H.; Carter, G.T. Drug-like property concepts in pharmaceutical design. Curr. Pharm. Des. 2009, 15, 2184–2194. [Google Scholar]
- Li, D.; Fish, P.V.; Mano, T. Bridging solubility between drug discovery and development. Drug Discov. Today 2012, 17, 486–495. [Google Scholar]
- Singh, A.; Worku, Z.A.; Van den Mooter, G. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin. Drug Del. 2011, 8, 1361–1378. [Google Scholar] [CrossRef] [PubMed]
- Williams, H.D.; Trevaskis, N.L.; Charman, S.A.; Shanker, R.M.; Charman, W.N.; Pouton, C.W.; Porter, C.J.H. Strategies to address low drug solubility in discovery and development. Pharmacol. Rev. 2013, 65, 315–499. [Google Scholar] [CrossRef]
- Fridgeirsdottir, G.A.; Harris, R.; Fischer, P.M.; Roberts, C.J. Support tools in formulation development for poorly soluble drugs. J. Pharm. Sci. 2016, 105, 2260–2269. [Google Scholar] [CrossRef]
- Filippatos, T.; Milionis, H.J. Treatment of hyperlipidaemia with fenofibrate and related fibrates. Expert Opin Investig Drugs 2008, 17, 1599–1614. [Google Scholar] [CrossRef]
- Ling, H.; Luoma, J.T.; Hilleman, D. A review of currently available fenofibrate and fenofibric acid formulations. Cardiol. Res. 2013, 4, 47. [Google Scholar] [CrossRef] [Green Version]
- Guay, D.R.P. Micronized fenofibrate: A new fibric acid hypolipidemic agent. Ann. Pharmacother. 1999, 33, 1083–1103. [Google Scholar] [CrossRef] [PubMed]
- Sharpe, M.; Ormrod, D.; Jarvis, B. Micronized Fenofibrate in Dyslipidemia: A focus on plasma high-density lipoprotein cholesterol (HDL-C) levels. Am. J. Cardiovasc. Drugs 2002, 2, 125–132. [Google Scholar] [CrossRef] [PubMed]
- Guichard, J.P.; Blouquin, P.; Qing, Y. A New Formulation of Fenofibrate: Suprabioavailable Tablets. Curr. Med. Res. Opin. 2000, 16, 134–138. [Google Scholar] [CrossRef] [PubMed]
- Ramjattan, B.R.; Callaghan, D.J.G.; Theiss, U. Efficacy and tolerability of a “suprabioavailable” formulation of fenofibrate in patients with dyslipidemia: A pooled analysis of two open-label trials. Clin. Ther. 2002, 24, 1105–1116. [Google Scholar] [CrossRef]
- Guivarc’h, P.-H.; Vachon, M.G.; Fordyce, D. A new fenofibrate formulation: Results of six single-dose, clinical studies of bioavailability under fed and fasting conditions. Clin. Ther. 2004, 26, 1456–1469. [Google Scholar] [CrossRef]
- Bahloul, B.; Lassoued, M.A.; Sfar, S. A novel approach for the development and optimization of self emulsifying drug delivery system using HLB and response surface methodology: Application to fenofibrate encapsulation. Int. J. Pharm. 2014, 466, 341–348. [Google Scholar] [CrossRef]
- Kanaujia, P.; Ng, W.K.; Tan, R.B.H. Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate. J. Microencapsul. 2014, 31, 293–298. [Google Scholar] [CrossRef]
- Truong, D.H.; Tran, T.H.; Ramasamy, T.; Choi, J.Y.; Lee, H.H.; Moon, C.; Choi, H.-G.; Yong, C.S.; Kim, J.O. Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib. AAPS PharmSciTech 2016, 17, 466–473. [Google Scholar] [CrossRef] [Green Version]
- Sauron, R.; Wilkins, M.; Jessent, V.; Dubois, A.; Maillot, C.; Weil, A. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation. Int. J. Clin. Pharmacol. Ther. 2006, 44. [Google Scholar] [CrossRef] [PubMed]
- Knieke, C.; Rawtani, A.; Davé, R.N. Concentrated fenofibrate nanoparticle suspensions from melt emulsification for enhanced drug dissolution. Chem. Eng. Technol. 2014, 37, 157–167. [Google Scholar] [CrossRef]
- Patil, H.; Feng, X.; Ye, X.; Majumdar, S.; Repka, M.A. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: A systematic study based on a quality by design approach. AAPS J. 2015, 17, 194–205. [Google Scholar] [CrossRef] [Green Version]
- Bhakay, A.; Vizzotti, E.; Li, M.; Davé, R.; Bilgili, E. Incorporation of fenofibrate nanoparticles prepared by melt emulsification into polymeric films. J. Pharm. Innov. 2016, 11, 53–63. [Google Scholar] [CrossRef]
- Zhang, M.; Li, H.; Lang, B.; O’Donnell, K.; Zhang, H.; Wang, Z.; Dong, Y.; Wu, C.; Williams, R.O. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing. Eur. J. Pharm. Biopharm. 2012, 82, 534–544. [Google Scholar] [CrossRef] [PubMed]
- Van Speybroeck, M.; Mellaerts, R.; Mols, R.; Do Thi, T.; Martens, J.A.; Van Humbeeck, J.; Annaert, P.; den Mooter, G.; Augustijns, P. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur. J. Pharm. Sci. 2010, 41, 623–630. [Google Scholar] [CrossRef] [PubMed]
- Ahern, R.J.; Hanrahan, J.P.; Tobin, J.M.; Ryan, K.B.; Crean, A.M. Comparison of fenofibrate--mesoporous silica drug-loading processes for enhanced drug delivery. Eur. J. Pharm. Sci. 2013, 50, 400–409. [Google Scholar] [CrossRef] [PubMed]
- Uejo, F.; Limwikrant, W.; Moribe, K.; Yamamoto, K. Dissolution improvement of fenofibrate by melting inclusion in mesoporous silica. Asian J. Pharm. Sci. 2013, 8, 329–335. [Google Scholar] [CrossRef] [Green Version]
- Hong, S.; Shen, S.; Tan, D.C.T.; Ng, W.K.; Liu, X.; Chia, L.S.O.; Irwan, A.W.; Tan, R.; Nowak, S.A.; Marsh, K.; et al. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: A comparison of spray drying versus solvent impregnation methods. Drug Deliv. 2016, 23, 316–327. [Google Scholar] [CrossRef]
- Bouledjouidja, A.; Masmoudi, Y.; Van Speybroeck, M.; Schueller, L.; Badens, E. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide. Int. J. Pharm. 2016, 499, 1–9. [Google Scholar] [CrossRef]
- Zhao, Z.; Wu, C.; Zhao, Y.; Hao, Y.; Liu, Y.; Zhao, W. Development of an oral push--pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles. Int. J. Nanomed. 2015, 10, 1691. [Google Scholar]
- Niu, X.; Wan, L.; Hou, Z.; Wang, T.; Sun, C.; Sun, J.; Zhao, P.; Jiang, T.; Wang, S. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability. Int. J. Pharm. 2013, 452, 382–389. [Google Scholar] [CrossRef]
- Xue, J.; Wu, T.; Dai, Y.; Xia, Y. Electrospinning and electrospun nanofibers: Methods, materials, and applications. Chem. Rev. 2019, 119, 5298–5415. [Google Scholar] [CrossRef]
- Ding, Y.; Li, W.; Zhang, F.; Liu, Z.; Zanjanizadeh Ezazi, N.; Liu, D.; Santos, H.A. Electrospun fibrous architectures for drug delivery, tissue engineering and cancer therapy. Adv. Funct. Mater. 2019, 29, 1802852. [Google Scholar] [CrossRef]
- Sebe, I.; Szabó, P.; Kállai-Szabó, B.; Zelkó, R. Incorporating small molecules or biologics into nanofibers for optimized drug release: A review. Int. J. Pharm. 2015, 494, 516–530. [Google Scholar] [CrossRef] [PubMed]
- Yu, D.-G.; Li, J.-J.; Williams, G.R.; Zhao, M. Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review. J. Control. Release 2018, 292, 91–110. [Google Scholar] [CrossRef] [Green Version]
- Nagy, Z.K.; Nyúl, K.; Wagner, I.; Molnár, K.; Marosi, G. Electrospun water soluble polymer mat for ultrafast release of Donepezil HCl. Express Polym. Lett. 2010, 4, 763–772. [Google Scholar] [CrossRef]
- Nagy, Z.K.; Balogh, A.; Démuth, B.; Pataki, H.; Vigh, T.; Szabó, B.; Molnár, K.; Schmidt, B.T.; Horák, P.; Marosi, G.; et al. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole. Int. J. Pharm. 2015, 480, 137–142. [Google Scholar] [CrossRef]
- Sipos, E.; Szabó, Z.I.; Rédai, E.; Szabó, P.; Sebe, I.; Zelkó, R. Preparation and characterization of nanofibrous sheets for enhanced oral dissolution of nebivolol hydrochloride. J. Pharm. Biomed. Anal. 2016, 129. [Google Scholar] [CrossRef]
- Yu, D.G.; Branford-White, C.; White, K.; Li, X.L.; Zhu, L.M. Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen. AAPS PharmSciTech 2010, 11, 809–817. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Zhang, D.; Xu, X.; Zhang, B. Morphology control and photocatalytic characterization of WO3 nanofiber bundles. Chinese Chem. Lett. 2018, 29, 1350–1354. [Google Scholar] [CrossRef]
- Li, Y.; Li, M.; Zhang, J.; Xu, X. Adsorption properties of the double-imprinted electrospun crosslinked chitosan nanofibers. Chinese Chem. Lett. 2019, 30, 762–766. [Google Scholar] [CrossRef]
- Kirkegaard, P.; Eldrup, M.; Mogensen, O.E.; Pedersen, N.J. Program system for analysing positron lifetime spectra and angular correlation curves. Comput. Phys. Commun. 1981, 23, 307–335. [Google Scholar] [CrossRef]
- Mukharya, A.; Chaudhary, S.; Mansuri, N.; Misra, A.K. Solid-state characterization of lacidipine/PVP K29/32 solid dispersion primed by solvent co-evaporation. Int. J. Pharm. Investig. 2012, 2, 90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sipos, E.; Kósa, N.; Kazsoki, A.; Szabó, Z.-I.; Zelkó, R. Formulation and characterization of aceclofenac-loaded nanofiber based orally dissolving webs. Pharmaceutics 2019, 11, 417. [Google Scholar] [CrossRef] [Green Version]
- Heinz, A.; Gordon, K.C.; McGoverin, C.M.; Rades, T.; Strachan, C.J. Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study. Eur. J. Pharm. Biopharm. 2009, 71, 100–108. [Google Scholar] [CrossRef] [PubMed]
- Sailaja, U.; Thayyil, M.S.; Kumar, N.S.K.; Govindaraj, G. Molecular dynamics of amorphous pharmaceutical fenofibrate studied by broadband dielectric spectroscopy. J. Pharm. Anal. 2016, 6, 165–170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tipduangta, P.; Takieddin, K.; Fábián, L.; Belton, P.; Qi, S. Towards controlling the crystallisation behaviour of fenofibrate melt: Triggers of crystallisation and polymorphic transformation. RSC Adv. 2018, 8, 13513–13525. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sipos, E.; Csatári, T.; Kazsoki, A.; Gergely, A.; Bitay, E.; Szabó, Z.-I.; Zelkó, R. Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets. Pharmaceutics 2020, 12, 612. https://doi.org/10.3390/pharmaceutics12070612
Sipos E, Csatári T, Kazsoki A, Gergely A, Bitay E, Szabó Z-I, Zelkó R. Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets. Pharmaceutics. 2020; 12(7):612. https://doi.org/10.3390/pharmaceutics12070612
Chicago/Turabian StyleSipos, Emese, Tamás Csatári, Adrienn Kazsoki, Attila Gergely, Enikő Bitay, Zoltán-István Szabó, and Romána Zelkó. 2020. "Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets" Pharmaceutics 12, no. 7: 612. https://doi.org/10.3390/pharmaceutics12070612
APA StyleSipos, E., Csatári, T., Kazsoki, A., Gergely, A., Bitay, E., Szabó, Z.-I., & Zelkó, R. (2020). Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets. Pharmaceutics, 12(7), 612. https://doi.org/10.3390/pharmaceutics12070612